The Science Behind ColdZyme – Insights from Professors

A study with athletes has shown that Enzymatica's oral spray, ColdZyme, significantly shortens the duration of upper respiratory tract infections...

14th of May 2025
Enzymatica

Enzymatica gears up for global expansion after strong first quarter

During the first quarter, Enzymatica's net sales increased by 30,3 percent to SEK 12,3 million. Sales increased the most in Sweden and...

5th of May 2025
Enzymatica

Enzymatica's results are published in The Journal of Physiology

Study results show that Enzymatica's ColdZyme oral spray reduces the amount of virus and inhibits its spread, leading to fewer sick days and milder...

March 11, 2025

Increased revenue in Q4 but potential for better partner sales for Enzymatica

The cold season is underway and it is also visible in Enzymatica's report for the fourth quarter, which showed increased sales compared to...

February 25
En

Enzymatica is recruiting an experienced marketing manager

Enzymatica strengthens its growth strategy by recruiting Anna Söderlund as Senior Director Marketing & Sales. With solid experience in...

January 14
Enzymatica

Enzymatica provides answers to questions

SBU has recently published an evaluation that points to some difficulty in assessing the effect of ColdZyme and other...

November 11
Glen Davison

Final study results: ColdZyme shortens illness duration and relieves symptoms

An independent study at the University of Kent shows that Enzymatica's ColdZyme oral spray reduces the duration of upper respiratory tract infections by up...

September 12
Enzymatica

Strengthened cash flow and adjusted business model will get Enzymatica back on track

After the record numbers before the pandemic, international sales of Enzymatica's cold spray ColdZyme have slowed down. The company is...

September 3
Claus Egstrand CEO Enzymatica

Enzymatica's CEO comments on business development and issue

Today marks the start of the subscription period for Enzymatica's rights issue, which will finance the continued establishment of ColdZyme in the cold medicine market. At the same time, the company is launching...

August 28
Enzymatica

MDR certification was Enzymatica's highlight during Q1

Enzymatica has recently published the Q1 report, where they highlight the MDR certification for ColdZyme as an important achievement.

29th April 2024
Enzymatica

Enzymatica comments on the MDR certification for ColdZyme

Enzymatica has received CE certification for ColdZyme according to the MDR, the EU's new regulation for medical devices. According to the company, this is a...

March 20, 2024
Enzymatica

Enzymatica prepares for expansion through issuance

Enzymatica is working to establish itself in the global market for over-the-counter cold products. The company has a distribution agreement for ColdZyme in...

March 4, 2024